Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease

Patients with diabetes and chronic kidney disease (CKD) are at particularly high risk for cardiovascular disease (CVD). This post hoc analysis from the PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive) investigated the relationship between CKD and incident CVD in a populati...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Christian Schneider, Ele Ferrannini, Ralph A. DeFronzo, Guntram Schernthaner, John Yates, Erland Erdmann
Formaat: Artigo
Taal:Engels
Gepubliceerd in: 2007
Online toegang:https://doi.org/10.1681/asn.2007060678
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!